Adjuvant nivolumab plus chemoradiotherapy “could be proposed as a new standard treatment,” said Jean Bourhis, MD, PhD.

For US adult cancer survivors with a new alcohol use disorder diagnosis, the 1-year cumulative incidence of treatment initiation was 14.3%.